Patents by Inventor Rakesh N. Veedu

Rakesh N. Veedu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thiomorpholino Oligonucleotides For The Treatment of Muscular Dystrophy
    Publication number: 20230193266
    Abstract: Improved compositions and methods for treating a disease or disorder through target exon skipping, and preferably muscular dystrophy by administering antisense thiomorpholino molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping to produce a functional Dystrophin protein.
    Type: Application
    Filed: September 27, 2022
    Publication date: June 22, 2023
    Inventors: Marvin Caruthers, Sibasish Paul, Rakesh N. Veedu, Katarzyna Jastrzebska, Heera Krishna
  • METHOD FOR TREATING CYCLOPHILIN A ASSOCIATED DISEASES
    Publication number: 20230193280
    Abstract: An isolated or purified antisense oligomer which has a modified backbone structure for modifying pre-mRNA splicing in the PPIA gene transcript or part thereof.
    Type: Application
    Filed: May 19, 2021
    Publication date: June 22, 2023
    Inventors: 6011 Boulos, Rakesh N. Veedu
  • Thiomorpholino oligonucleotides for the treatment of muscular dystrophy
    Patent number: 11479772
    Abstract: Improved compositions and methods for treating a disease or disorder through target exon skipping, and preferably muscular dystrophy by administering antisense thiomorpholino molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping to produce a functional Dystrophin protein.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: October 25, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO
    Inventors: Marvin Caruthers, Sibasish Paul, Rakesh N. Veedu, Katarzyna Jastrzebska, Heera Krishna
  • Thiomorpholino Oligonucleotides For The Treatment of Muscular Dystrophy
    Publication number: 20200308586
    Abstract: Improved compositions and methods for treating a disease or disorder through target exon skipping, and preferably muscular dystrophy by administering antisense thiomorpholino molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping to produce a functional Dystrophin protein.
    Type: Application
    Filed: March 20, 2020
    Publication date: October 1, 2020
    Inventors: Marvin Caruthers, Sibasish Paul, Rakesh N. Veedu, Katarzyna Jastrzebska, Heera Krishna